Keybanc analyst Aleksey Yefremov downgrades Dow (NYSE:DOW) from Sector Weight to Underweight and announces $45 price target.
Analyst Expectations for Outlook Therapeutics’s Future
Outlook Therapeutics (NASDAQ:OTLK) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…